Oral Pathology Evaluation in Beaverton, OR

Oral pathology is the dental specialty concerned with the identification, diagnosis, and management of diseases affecting the oral and maxillofacial region — including the lips, tongue, cheeks, palate, gums, salivary glands, jawbones, and surrounding tissues. It encompasses a wide range of conditions from common benign growths (such as fibromas and mucoceles) to potentially life-threatening malignancies (such as oral squamous cell carcinoma). Oral pathology evaluation involves clinical examination, biopsy when indicated, and microscopic analysis of tissue samples to reach a definitive diagnosis.

A biopsy is a procedure in which a small sample of tissue is removed from a suspicious area and sent to a pathology laboratory for microscopic examination. You may need a biopsy if your dentist or oral surgeon identifies a lesion that does not match any definitively diagnosable clinical entity, has been present for more than two weeks without improvement, has features that suggest dysplasia or malignancy (such as irregular borders, mixed colors, induration, or rapid growth), or needs a definitive diagnosis before treatment planning can proceed. Biopsy is the gold standard for diagnosing oral lesions — clinical visual examination alone is insufficient to determine whether a lesion is benign or malignant.

An incisional biopsy removes a representative portion of the lesion for diagnosis — it is used when the lesion is large, when complete removal would require more extensive surgery, or when a diagnosis is needed before definitive treatment planning. An excisional biopsy removes the entire lesion, serving as both a diagnostic and therapeutic procedure. Excisional biopsies are appropriate for small, well-defined lesions where complete removal is feasible without significant morbidity. The choice between incisional and excisional biopsy depends on the size, location, and clinical characteristics of the lesion.

Oral biopsies are performed under local anesthesia, and you should not feel pain during the procedure. The injection of anesthetic may cause a brief pinch, but the biopsy itself is painless. Most biopsies are completed in 10 to 20 minutes. Post-procedural discomfort is typically mild — most patients describe it as similar to a minor cut inside the mouth. Over-the-counter ibuprofen or acetaminophen provides adequate relief for most cases. We offer sedation options for patients who are anxious about the procedure.

Leukoplakia is a clinical term for a white patch or plaque on the oral mucosa that cannot be rubbed off and cannot be diagnosed as any other specific entity. It is a clinical description, not a diagnosis — the term simply identifies a lesion that requires further evaluation. While most leukoplakia is benign (caused by chronic irritation, tobacco use, or other factors), approximately 5–25% of leukoplakia shows some degree of epithelial dysplasia on biopsy, and a small percentage represents early carcinoma. This variability is exactly why biopsy is essential for any persistent white patch in the mouth.

Erythroplakia is a red patch on the oral mucosa that cannot be attributed to any other diagnosable condition. It is far less common than leukoplakia but far more dangerous — studies show that over 50% of erythroplakia lesions contain severe dysplasia or carcinoma at the time of biopsy. Any persistent red patch in the mouth that does not resolve within two weeks should be evaluated promptly by an oral surgeon. Erythroplakia has a higher rate of malignant transformation than any other oral mucosal lesion, making early biopsy and diagnosis critical.

The primary risk factors for oral cancer include tobacco use (smoking, chewing tobacco, and smokeless tobacco products), heavy alcohol consumption, the combination of tobacco and alcohol (which has a synergistic effect on cancer risk), infection with high-risk strains of human papillomavirus (HPV, particularly HPV-16), chronic sun exposure (for lip cancers), a history of previous oral cancer or head and neck cancer, immunosuppression, and a diet low in fruits and vegetables. However, approximately 25% of oral cancers occur in patients with no identifiable risk factors, which is why routine oral cancer screening is important for everyone.

Pathology results typically take five to ten business days from the time the specimen is submitted to the laboratory. The turnaround time depends on the complexity of the case — straightforward diagnoses are often reported within five to seven days, while cases requiring special stains, immunohistochemistry, or consultation with additional pathologists may take longer. We understand that waiting for biopsy results can be stressful, and we contact you as soon as the report is available to review the findings and discuss next steps.

If the biopsy reveals oral cancer, we act quickly and methodically. We review the pathology report in detail with you, explain the type and stage of cancer, and immediately coordinate referral to an oncology team — typically including a head and neck surgeon, medical oncologist, and radiation oncologist — who specialize in treating oral malignancies. Treatment options depend on the type, location, size, and stage of the cancer, and may include surgery, radiation therapy, chemotherapy, or a combination. Early-stage oral cancers have excellent survival rates when treated promptly, which is why our emphasis on early detection through timely biopsy is so important.

Common benign oral lesions that may require biopsy include: fibromas (firm, smooth growths resulting from chronic irritation), mucoceles (fluid-filled swellings from minor salivary gland trauma), pyogenic granulomas (vascular growths that bleed easily), peripheral giant cell granulomas (gum growths typically in the posterior region), papillomas (small, wart-like growths associated with HPV), lichen planus (white, lacy patterns on the cheek mucosa), and various cysts of the jawbone. Even when a lesion appears clinically benign, biopsy provides definitive confirmation and rules out unexpected pathology.

Yes — any oral ulcer or sore that does not heal within two weeks should be evaluated by a dental professional. While most oral ulcers are caused by trauma, canker sores (aphthous ulcers), or other benign conditions and resolve on their own, a non-healing ulcer is one of the classic warning signs of oral cancer. Other concerning features include a hardened or rolled border around the ulcer, numbness in the adjacent tissue, a fixated mass beneath the ulcer, and unexplained bleeding. Do not assume that a persistent sore is harmless — early evaluation could be life-saving.

Dysplasia refers to abnormal cellular changes in the epithelium (the lining tissue of the mouth) that are considered precancerous. Dysplasia is graded as mild, moderate, or severe based on how much of the epithelial thickness is affected by abnormal cells. Mild dysplasia involves changes in the lower third of the epithelium, moderate involves the lower two-thirds, and severe (also called carcinoma in situ when the full thickness is affected) involves the entire epithelial layer without invasion through the basement membrane. The presence and grade of dysplasia determine the follow-up plan — which may range from close observation with repeat biopsies for mild dysplasia to excision and frequent monitoring for severe dysplasia.

The American Dental Association recommends that dentists perform a visual and tactile oral cancer screening at every routine dental examination. Patients at higher risk — including those who use tobacco, consume alcohol heavily, have a history of HPV infection, have a previous oral cancer history, or are over age 55 — should be particularly vigilant and report any changes to their dentist promptly. If your dentist identifies a lesion that warrants specialist evaluation, a referral to our practice ensures that the lesion receives expert assessment and timely biopsy if indicated.

Most dental and medical insurance plans provide coverage for oral biopsies and pathology evaluation, as these are diagnostic procedures. The surgical biopsy may be covered under dental insurance (surgical code), while the laboratory pathology analysis may be covered under medical insurance. We submit claims to both dental and medical insurance when applicable to maximize your benefits. Our administrative team verifies your coverage before the procedure and provides a clear estimate of any out-of-pocket costs.

Human papillomavirus (HPV), particularly high-risk strain HPV-16, has emerged as a significant risk factor for oropharyngeal cancers (cancers of the base of tongue, tonsils, and soft palate). HPV-associated oropharyngeal cancers have increased dramatically over the past two decades and now surpass tobacco-associated cases in many populations. HPV-positive oral cancers tend to occur in younger patients and generally have a better prognosis than HPV-negative cancers with appropriate treatment. During biopsy, immunohistochemical testing for p16 (a surrogate marker for HPV) can help identify HPV-associated lesions. HPV vaccination is recommended as a preventive measure and has been shown to reduce the incidence of HPV-associated cancers.